Cargando…

Granulocyte-macrophage colony-stimulating factor receptor expression in clinical pain disorder tissues and role in neuronal sensitization

INTRODUCTION: Granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR) is highly expressed in peripheral macrophages and microglia, and is involved in arthritis and cancer pain in animal models. However, there is limited information on GM-CSFR expression in human central nervous system (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Donatien, Philippe, Anand, Uma, Yiangou, Yiangos, Sinisi, Marco, Fox, Michael, MacQuillan, Anthony, Quick, Tom, Korchev, Yuri E., Anand, Praveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181465/
https://www.ncbi.nlm.nih.gov/pubmed/30534627
http://dx.doi.org/10.1097/PR9.0000000000000676
_version_ 1783362404286988288
author Donatien, Philippe
Anand, Uma
Yiangou, Yiangos
Sinisi, Marco
Fox, Michael
MacQuillan, Anthony
Quick, Tom
Korchev, Yuri E.
Anand, Praveen
author_facet Donatien, Philippe
Anand, Uma
Yiangou, Yiangos
Sinisi, Marco
Fox, Michael
MacQuillan, Anthony
Quick, Tom
Korchev, Yuri E.
Anand, Praveen
author_sort Donatien, Philippe
collection PubMed
description INTRODUCTION: Granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR) is highly expressed in peripheral macrophages and microglia, and is involved in arthritis and cancer pain in animal models. However, there is limited information on GM-CSFR expression in human central nervous system (CNS), peripheral nerves, or dorsal root ganglia (DRG), particularly in chronic pain conditions. OBJECTIVES: Immunohistochemistry was used to quantify GM-CSFR expression levels in human tissues, and functional sensory effects of GM-CSF were studied in cultured DRG neurons. RESULTS: Granulocyte-macrophage colony-stimulating factor receptor was markedly increased in microglia at lesional sites of multiple sclerosis spinal cords (P = 0.01), which co-localised with macrophage marker CD68 (P = 0.009). In human DRG, GM-CSFR was expressed in a subset of small/medium diameter cells (30%) and few large cells (10%), with no significant change in avulsion-injured DRG. In peripheral nerves, there was a marked decrease in axonal GM-CSFR after chronic painful nerve injury (P = 0.004) and in painful neuromas (P = 0.0043); CD-68–positive macrophages were increased (P = 0.017) but did not appear to express GM-CSFR. Although control synovium showed absent GM-CSFR immunostaining, this was markedly increased in macrophages of painful osteoarthritis knee synovium. Granulocyte-macrophage colony-stimulating factor receptor was expressed in 17 ± 1.7% of small-/medium-sized cultured adult rat DRG neurons, and in 27 ± 3.3% of TRPV1-positive neurons. Granulocyte-macrophage colony-stimulating factor treatment sensitized capsaicin responses in vitro, which were diminished by p38 MAPK or TrkA inhibitors. CONCLUSION: Our findings support GM-CSFR as a therapeutic target for pain and hypersensitivity in clinical CNS and peripheral inflammatory conditions. Although GM-CSFR was decreased in chronic painful injured peripheral nerves, it could mediate CNS neuroinflammatory effects, which deserves study.
format Online
Article
Text
id pubmed-6181465
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-61814652018-12-10 Granulocyte-macrophage colony-stimulating factor receptor expression in clinical pain disorder tissues and role in neuronal sensitization Donatien, Philippe Anand, Uma Yiangou, Yiangos Sinisi, Marco Fox, Michael MacQuillan, Anthony Quick, Tom Korchev, Yuri E. Anand, Praveen Pain Rep Basic Science INTRODUCTION: Granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR) is highly expressed in peripheral macrophages and microglia, and is involved in arthritis and cancer pain in animal models. However, there is limited information on GM-CSFR expression in human central nervous system (CNS), peripheral nerves, or dorsal root ganglia (DRG), particularly in chronic pain conditions. OBJECTIVES: Immunohistochemistry was used to quantify GM-CSFR expression levels in human tissues, and functional sensory effects of GM-CSF were studied in cultured DRG neurons. RESULTS: Granulocyte-macrophage colony-stimulating factor receptor was markedly increased in microglia at lesional sites of multiple sclerosis spinal cords (P = 0.01), which co-localised with macrophage marker CD68 (P = 0.009). In human DRG, GM-CSFR was expressed in a subset of small/medium diameter cells (30%) and few large cells (10%), with no significant change in avulsion-injured DRG. In peripheral nerves, there was a marked decrease in axonal GM-CSFR after chronic painful nerve injury (P = 0.004) and in painful neuromas (P = 0.0043); CD-68–positive macrophages were increased (P = 0.017) but did not appear to express GM-CSFR. Although control synovium showed absent GM-CSFR immunostaining, this was markedly increased in macrophages of painful osteoarthritis knee synovium. Granulocyte-macrophage colony-stimulating factor receptor was expressed in 17 ± 1.7% of small-/medium-sized cultured adult rat DRG neurons, and in 27 ± 3.3% of TRPV1-positive neurons. Granulocyte-macrophage colony-stimulating factor treatment sensitized capsaicin responses in vitro, which were diminished by p38 MAPK or TrkA inhibitors. CONCLUSION: Our findings support GM-CSFR as a therapeutic target for pain and hypersensitivity in clinical CNS and peripheral inflammatory conditions. Although GM-CSFR was decreased in chronic painful injured peripheral nerves, it could mediate CNS neuroinflammatory effects, which deserves study. Wolters Kluwer 2018-09-17 /pmc/articles/PMC6181465/ /pubmed/30534627 http://dx.doi.org/10.1097/PR9.0000000000000676 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The International Association for the Study of Pain. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Basic Science
Donatien, Philippe
Anand, Uma
Yiangou, Yiangos
Sinisi, Marco
Fox, Michael
MacQuillan, Anthony
Quick, Tom
Korchev, Yuri E.
Anand, Praveen
Granulocyte-macrophage colony-stimulating factor receptor expression in clinical pain disorder tissues and role in neuronal sensitization
title Granulocyte-macrophage colony-stimulating factor receptor expression in clinical pain disorder tissues and role in neuronal sensitization
title_full Granulocyte-macrophage colony-stimulating factor receptor expression in clinical pain disorder tissues and role in neuronal sensitization
title_fullStr Granulocyte-macrophage colony-stimulating factor receptor expression in clinical pain disorder tissues and role in neuronal sensitization
title_full_unstemmed Granulocyte-macrophage colony-stimulating factor receptor expression in clinical pain disorder tissues and role in neuronal sensitization
title_short Granulocyte-macrophage colony-stimulating factor receptor expression in clinical pain disorder tissues and role in neuronal sensitization
title_sort granulocyte-macrophage colony-stimulating factor receptor expression in clinical pain disorder tissues and role in neuronal sensitization
topic Basic Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181465/
https://www.ncbi.nlm.nih.gov/pubmed/30534627
http://dx.doi.org/10.1097/PR9.0000000000000676
work_keys_str_mv AT donatienphilippe granulocytemacrophagecolonystimulatingfactorreceptorexpressioninclinicalpaindisordertissuesandroleinneuronalsensitization
AT ananduma granulocytemacrophagecolonystimulatingfactorreceptorexpressioninclinicalpaindisordertissuesandroleinneuronalsensitization
AT yiangouyiangos granulocytemacrophagecolonystimulatingfactorreceptorexpressioninclinicalpaindisordertissuesandroleinneuronalsensitization
AT sinisimarco granulocytemacrophagecolonystimulatingfactorreceptorexpressioninclinicalpaindisordertissuesandroleinneuronalsensitization
AT foxmichael granulocytemacrophagecolonystimulatingfactorreceptorexpressioninclinicalpaindisordertissuesandroleinneuronalsensitization
AT macquillananthony granulocytemacrophagecolonystimulatingfactorreceptorexpressioninclinicalpaindisordertissuesandroleinneuronalsensitization
AT quicktom granulocytemacrophagecolonystimulatingfactorreceptorexpressioninclinicalpaindisordertissuesandroleinneuronalsensitization
AT korchevyurie granulocytemacrophagecolonystimulatingfactorreceptorexpressioninclinicalpaindisordertissuesandroleinneuronalsensitization
AT anandpraveen granulocytemacrophagecolonystimulatingfactorreceptorexpressioninclinicalpaindisordertissuesandroleinneuronalsensitization